PTP4A3 and cancer: However, the criteria for PRL-3-targeted therapy have not been established, and it is critical to clarify the characteristics of PRL-3 genomic amplification in the both mechanistic and therapeutic points of view, because of the major mechanism of its consequent expression and the cancer development [10].